Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Dec;33(6):725-738.
doi: 10.1007/s10557-019-06920-x.

Drug-Induced Pulmonary Arterial Hypertension: Mechanisms and Clinical Management

Affiliations
Review

Drug-Induced Pulmonary Arterial Hypertension: Mechanisms and Clinical Management

Michele Correale et al. Cardiovasc Drugs Ther. 2019 Dec.

Abstract

Pulmonary arterial hypertension is a rare disease, with drug-induced causes even more uncommon, accounting for only 10% of cases in large registry series. Predisposing factors for drug-induced PAH have not been completely defined. This review summarizes drugs with definite, possible, or likely association to pulmonary hypertension and possible mechanisms involved in the occurrence of pulmonary hypertension. Controversies on mechanisms and on their role in pathophysiology were also shown. The possible synergism between drug abuse and HIV was discussed and the possible interactions of antiretroviral therapy in HIV subjects were analyzed. Furthermore, we reported clinical findings and possible management, specific for each class of drugs, in case of drug-induced PAH. Finally, we summarized into a unified algorithm possible management of drug-induced PAH.

Keywords: Drug-induced pulmonary hypertension; Pulmonary arterial hypertension; Pulmonary hypertension.

PubMed Disclaimer

MeSH terms

Substances

LinkOut - more resources